nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP3A4—Ifosfamide—germ cell cancer	0.0739	0.266	CbGbCtD
Cyclobenzaprine—CYP1A2—Etoposide—germ cell cancer	0.0674	0.243	CbGbCtD
Cyclobenzaprine—CYP2D6—Vinblastine—germ cell cancer	0.0616	0.222	CbGbCtD
Cyclobenzaprine—HTR2A—phrenic nerve—germ cell cancer	0.0419	0.16	CbGeAlD
Cyclobenzaprine—CYP3A4—Vinblastine—germ cell cancer	0.0392	0.141	CbGbCtD
Cyclobenzaprine—CYP3A4—Etoposide—germ cell cancer	0.0353	0.127	CbGbCtD
Cyclobenzaprine—HTR2A—choroid plexus—germ cell cancer	0.0303	0.115	CbGeAlD
Cyclobenzaprine—HTR2A—myenteric nerve plexus—germ cell cancer	0.0215	0.0819	CbGeAlD
Cyclobenzaprine—HTR2A—trigeminal nerve—germ cell cancer	0.0153	0.0584	CbGeAlD
Cyclobenzaprine—HTR2A—vagus nerve—germ cell cancer	0.0143	0.0546	CbGeAlD
Cyclobenzaprine—HTR2A—cranial nerve—germ cell cancer	0.0109	0.0416	CbGeAlD
Cyclobenzaprine—HTR2A—pons—germ cell cancer	0.0108	0.0411	CbGeAlD
Cyclobenzaprine—CYP1A2—urine—germ cell cancer	0.0104	0.0395	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalic ventricle—germ cell cancer	0.00887	0.0338	CbGeAlD
Cyclobenzaprine—HTR2A—urine—germ cell cancer	0.0081	0.0309	CbGeAlD
Cyclobenzaprine—HTR2A—appendage—germ cell cancer	0.00789	0.0301	CbGeAlD
Cyclobenzaprine—HTR2A—pineal body—germ cell cancer	0.0077	0.0294	CbGeAlD
Cyclobenzaprine—CYP3A4—urine—germ cell cancer	0.0075	0.0286	CbGeAlD
Cyclobenzaprine—CYP2D6—urine—germ cell cancer	0.00738	0.0282	CbGeAlD
Cyclobenzaprine—HTR2A—ganglion—germ cell cancer	0.00552	0.0211	CbGeAlD
Cyclobenzaprine—HTR2A—endothelium—germ cell cancer	0.00476	0.0182	CbGeAlD
Cyclobenzaprine—HTR2A—blood vessel—germ cell cancer	0.00439	0.0167	CbGeAlD
Cyclobenzaprine—HTR2A—neck—germ cell cancer	0.00314	0.012	CbGeAlD
Cyclobenzaprine—HTR2A—embryo—germ cell cancer	0.00262	0.00999	CbGeAlD
Cyclobenzaprine—HTR2A—brainstem—germ cell cancer	0.0024	0.00915	CbGeAlD
Cyclobenzaprine—HTR2A—eye—germ cell cancer	0.00234	0.00891	CbGeAlD
Cyclobenzaprine—HTR2A—retina—germ cell cancer	0.00232	0.00883	CbGeAlD
Cyclobenzaprine—CYP2D6—brainstem—germ cell cancer	0.00219	0.00834	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalon—germ cell cancer	0.00213	0.00812	CbGeAlD
Cyclobenzaprine—CYP2D6—telencephalon—germ cell cancer	0.00194	0.0074	CbGeAlD
Cyclobenzaprine—Convulsion—Vinblastine—germ cell cancer	0.00184	0.004	CcSEcCtD
Cyclobenzaprine—Hypertension—Vinblastine—germ cell cancer	0.00183	0.00398	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Ifosfamide—germ cell cancer	0.00183	0.00397	CcSEcCtD
Cyclobenzaprine—Alopecia—Bleomycin—germ cell cancer	0.00182	0.00395	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Cisplatin—germ cell cancer	0.0018	0.00391	CcSEcCtD
Cyclobenzaprine—Discomfort—Vinblastine—germ cell cancer	0.00179	0.00388	CcSEcCtD
Cyclobenzaprine—HTR2A—gonad—germ cell cancer	0.00178	0.00678	CbGeAlD
Cyclobenzaprine—Hepatitis—Ifosfamide—germ cell cancer	0.00176	0.00382	CcSEcCtD
Cyclobenzaprine—Dysarthria—Methotrexate—germ cell cancer	0.00175	0.00381	CcSEcCtD
Cyclobenzaprine—Hallucination—Ifosfamide—germ cell cancer	0.00175	0.0038	CcSEcCtD
Cyclobenzaprine—HTR2A—pituitary gland—germ cell cancer	0.00173	0.00662	CbGeAlD
Cyclobenzaprine—CYP1A2—endocrine gland—germ cell cancer	0.00172	0.00655	CbGeAlD
Cyclobenzaprine—Alopecia—Dactinomycin—germ cell cancer	0.0017	0.00369	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Vinblastine—germ cell cancer	0.0017	0.00368	CcSEcCtD
Cyclobenzaprine—HTR2A—medulla oblongata—germ cell cancer	0.00167	0.00638	CbGeAlD
Cyclobenzaprine—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00167	0.00362	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Bleomycin—germ cell cancer	0.00166	0.00361	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Cisplatin—germ cell cancer	0.00166	0.0036	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00166	0.0036	CcSEcCtD
Cyclobenzaprine—Anorexia—Vinblastine—germ cell cancer	0.00165	0.00359	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Etoposide—germ cell cancer	0.00165	0.00358	CcSEcCtD
Cyclobenzaprine—Stomatitis—Cisplatin—germ cell cancer	0.00165	0.00358	CcSEcCtD
Cyclobenzaprine—Tinnitus—Ifosfamide—germ cell cancer	0.00164	0.00356	CcSEcCtD
Cyclobenzaprine—Malaise—Bleomycin—germ cell cancer	0.00162	0.00351	CcSEcCtD
Cyclobenzaprine—Leukopenia—Bleomycin—germ cell cancer	0.0016	0.00349	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Ifosfamide—germ cell cancer	0.00157	0.00342	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Vinblastine—germ cell cancer	0.00156	0.00338	CcSEcCtD
Cyclobenzaprine—Alopecia—Ifosfamide—germ cell cancer	0.00156	0.00338	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00155	0.00337	CcSEcCtD
Cyclobenzaprine—HTR2A—adrenal gland—germ cell cancer	0.00155	0.00591	CbGeAlD
Cyclobenzaprine—HTR2A—midbrain—germ cell cancer	0.00153	0.00583	CbGeAlD
Cyclobenzaprine—Acute coronary syndrome—Etoposide—germ cell cancer	0.00153	0.00332	CcSEcCtD
Cyclobenzaprine—Myalgia—Bleomycin—germ cell cancer	0.00153	0.00332	CcSEcCtD
Cyclobenzaprine—Chest pain—Bleomycin—germ cell cancer	0.00153	0.00332	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Etoposide—germ cell cancer	0.00152	0.0033	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Etoposide—germ cell cancer	0.00152	0.0033	CcSEcCtD
Cyclobenzaprine—Jaundice—Etoposide—germ cell cancer	0.00151	0.00328	CcSEcCtD
Cyclobenzaprine—Stomatitis—Etoposide—germ cell cancer	0.00151	0.00328	CcSEcCtD
Cyclobenzaprine—Discomfort—Bleomycin—germ cell cancer	0.00151	0.00328	CcSEcCtD
Cyclobenzaprine—Malaise—Dactinomycin—germ cell cancer	0.00151	0.00328	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Vinblastine—germ cell cancer	0.00151	0.00327	CcSEcCtD
Cyclobenzaprine—Leukopenia—Dactinomycin—germ cell cancer	0.0015	0.00325	CcSEcCtD
Cyclobenzaprine—HTR2A—spinal cord—germ cell cancer	0.00149	0.00569	CbGeAlD
Cyclobenzaprine—Gynaecomastia—Methotrexate—germ cell cancer	0.00148	0.00322	CcSEcCtD
Cyclobenzaprine—Constipation—Vinblastine—germ cell cancer	0.00148	0.00322	CcSEcCtD
Cyclobenzaprine—Confusional state—Bleomycin—germ cell cancer	0.00148	0.0032	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00146	0.00318	CcSEcCtD
Cyclobenzaprine—Oedema—Bleomycin—germ cell cancer	0.00146	0.00318	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Etoposide—germ cell cancer	0.00145	0.00314	CcSEcCtD
Cyclobenzaprine—Vision blurred—Ifosfamide—germ cell cancer	0.00144	0.00314	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Bleomycin—germ cell cancer	0.00143	0.00311	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Vinblastine—germ cell cancer	0.00143	0.0031	CcSEcCtD
Cyclobenzaprine—Myalgia—Dactinomycin—germ cell cancer	0.00142	0.00309	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00142	0.00309	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00142	0.00308	CcSEcCtD
Cyclobenzaprine—Tinnitus—Cisplatin—germ cell cancer	0.00141	0.00307	CcSEcCtD
Cyclobenzaprine—Agitation—Ifosfamide—germ cell cancer	0.00141	0.00306	CcSEcCtD
Cyclobenzaprine—Discomfort—Dactinomycin—germ cell cancer	0.00141	0.00306	CcSEcCtD
Cyclobenzaprine—Angioedema—Ifosfamide—germ cell cancer	0.0014	0.00304	CcSEcCtD
Cyclobenzaprine—Anorexia—Bleomycin—germ cell cancer	0.00139	0.00303	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Etoposide—germ cell cancer	0.00138	0.003	CcSEcCtD
Cyclobenzaprine—Malaise—Ifosfamide—germ cell cancer	0.00138	0.003	CcSEcCtD
Cyclobenzaprine—Vertigo—Ifosfamide—germ cell cancer	0.00138	0.00299	CcSEcCtD
Cyclobenzaprine—Leukopenia—Ifosfamide—germ cell cancer	0.00137	0.00298	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Vinblastine—germ cell cancer	0.00137	0.00298	CcSEcCtD
Cyclobenzaprine—Hypotension—Bleomycin—germ cell cancer	0.00137	0.00297	CcSEcCtD
Cyclobenzaprine—Oedema—Dactinomycin—germ cell cancer	0.00136	0.00296	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Cisplatin—germ cell cancer	0.00136	0.00294	CcSEcCtD
Cyclobenzaprine—Palpitations—Ifosfamide—germ cell cancer	0.00135	0.00294	CcSEcCtD
Cyclobenzaprine—HTR2A—endocrine gland—germ cell cancer	0.00134	0.00512	CbGeAlD
Cyclobenzaprine—Alopecia—Cisplatin—germ cell cancer	0.00134	0.00291	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00134	0.0029	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00133	0.0029	CcSEcCtD
Cyclobenzaprine—Convulsion—Ifosfamide—germ cell cancer	0.00133	0.00288	CcSEcCtD
Cyclobenzaprine—HTR2A—head—germ cell cancer	0.00133	0.00506	CbGeAlD
Cyclobenzaprine—Hypertension—Ifosfamide—germ cell cancer	0.00132	0.00287	CcSEcCtD
Cyclobenzaprine—CYP2D6—female gonad—germ cell cancer	0.00132	0.00502	CbGeAlD
Cyclobenzaprine—Paraesthesia—Bleomycin—germ cell cancer	0.00131	0.00285	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Bleomycin—germ cell cancer	0.0013	0.00283	CcSEcCtD
Cyclobenzaprine—Myalgia—Ifosfamide—germ cell cancer	0.0013	0.00283	CcSEcCtD
Cyclobenzaprine—Chest pain—Ifosfamide—germ cell cancer	0.0013	0.00283	CcSEcCtD
Cyclobenzaprine—Flatulence—Cisplatin—germ cell cancer	0.0013	0.00283	CcSEcCtD
Cyclobenzaprine—Anorexia—Dactinomycin—germ cell cancer	0.0013	0.00283	CcSEcCtD
Cyclobenzaprine—Discomfort—Ifosfamide—germ cell cancer	0.00129	0.0028	CcSEcCtD
Cyclobenzaprine—HTR2A—testis—germ cell cancer	0.00128	0.00489	CbGeAlD
Cyclobenzaprine—Hypersensitivity—Vinblastine—germ cell cancer	0.00128	0.00277	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Bleomycin—germ cell cancer	0.00127	0.00276	CcSEcCtD
Cyclobenzaprine—Confusional state—Ifosfamide—germ cell cancer	0.00126	0.00274	CcSEcCtD
Cyclobenzaprine—Oedema—Ifosfamide—germ cell cancer	0.00125	0.00272	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00125	0.00272	CcSEcCtD
Cyclobenzaprine—Vision blurred—Cisplatin—germ cell cancer	0.00124	0.0027	CcSEcCtD
Cyclobenzaprine—CYP3A4—endocrine gland—germ cell cancer	0.00124	0.00474	CbGeAlD
Cyclobenzaprine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00124	0.0027	CcSEcCtD
Cyclobenzaprine—Asthenia—Vinblastine—germ cell cancer	0.00124	0.0027	CcSEcCtD
Cyclobenzaprine—Tremor—Cisplatin—germ cell cancer	0.00124	0.00269	CcSEcCtD
Cyclobenzaprine—Alopecia—Etoposide—germ cell cancer	0.00123	0.00267	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00123	0.00267	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Cisplatin—germ cell cancer	0.00123	0.00266	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00122	0.00266	CcSEcCtD
Cyclobenzaprine—CYP2D6—endocrine gland—germ cell cancer	0.00122	0.00467	CbGeAlD
Cyclobenzaprine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00121	0.00263	CcSEcCtD
Cyclobenzaprine—CYP2D6—head—germ cell cancer	0.00121	0.00461	CbGeAlD
Cyclobenzaprine—Feeling abnormal—Bleomycin—germ cell cancer	0.00121	0.00262	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Methotrexate—germ cell cancer	0.0012	0.00261	CcSEcCtD
Cyclobenzaprine—Anorexia—Ifosfamide—germ cell cancer	0.00119	0.00259	CcSEcCtD
Cyclobenzaprine—Malaise—Cisplatin—germ cell cancer	0.00119	0.00259	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Dactinomycin—germ cell cancer	0.00119	0.00258	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Vinblastine—germ cell cancer	0.00119	0.00257	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Etoposide—germ cell cancer	0.00119	0.00257	CcSEcCtD
Cyclobenzaprine—HTR2A—cerebellum—germ cell cancer	0.00118	0.00451	CbGeAlD
Cyclobenzaprine—Leukopenia—Cisplatin—germ cell cancer	0.00118	0.00257	CcSEcCtD
Cyclobenzaprine—Fatigue—Dactinomycin—germ cell cancer	0.00118	0.00256	CcSEcCtD
Cyclobenzaprine—Hypotension—Ifosfamide—germ cell cancer	0.00117	0.00254	CcSEcCtD
Cyclobenzaprine—CYP2D6—testis—germ cell cancer	0.00117	0.00445	CbGeAlD
Cyclobenzaprine—Urticaria—Bleomycin—germ cell cancer	0.00116	0.00253	CcSEcCtD
Cyclobenzaprine—Irritability—Methotrexate—germ cell cancer	0.00115	0.0025	CcSEcCtD
Cyclobenzaprine—Dizziness—Vinblastine—germ cell cancer	0.00115	0.00249	CcSEcCtD
Cyclobenzaprine—Convulsion—Cisplatin—germ cell cancer	0.00114	0.00249	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00114	0.00247	CcSEcCtD
Cyclobenzaprine—Ataxia—Methotrexate—germ cell cancer	0.00113	0.00246	CcSEcCtD
Cyclobenzaprine—Myalgia—Cisplatin—germ cell cancer	0.00112	0.00244	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00112	0.00244	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Ifosfamide—germ cell cancer	0.00112	0.00244	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Etoposide—germ cell cancer	0.00112	0.00244	CcSEcCtD
Cyclobenzaprine—Anxiety—Cisplatin—germ cell cancer	0.00112	0.00243	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00112	0.00242	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Ifosfamide—germ cell cancer	0.00111	0.00242	CcSEcCtD
Cyclobenzaprine—Somnolence—Ifosfamide—germ cell cancer	0.00111	0.00241	CcSEcCtD
Cyclobenzaprine—Discomfort—Cisplatin—germ cell cancer	0.00111	0.00241	CcSEcCtD
Cyclobenzaprine—Vomiting—Vinblastine—germ cell cancer	0.0011	0.00239	CcSEcCtD
Cyclobenzaprine—Malaise—Etoposide—germ cell cancer	0.00109	0.00237	CcSEcCtD
Cyclobenzaprine—Vertigo—Etoposide—germ cell cancer	0.00109	0.00236	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Ifosfamide—germ cell cancer	0.00109	0.00236	CcSEcCtD
Cyclobenzaprine—Headache—Vinblastine—germ cell cancer	0.00109	0.00236	CcSEcCtD
Cyclobenzaprine—Leukopenia—Etoposide—germ cell cancer	0.00108	0.00235	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Dactinomycin—germ cell cancer	0.00108	0.00234	CcSEcCtD
Cyclobenzaprine—CYP2D6—cerebellum—germ cell cancer	0.00108	0.00411	CbGeAlD
Cyclobenzaprine—Fatigue—Ifosfamide—germ cell cancer	0.00108	0.00234	CcSEcCtD
Cyclobenzaprine—Oedema—Cisplatin—germ cell cancer	0.00108	0.00234	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Cisplatin—germ cell cancer	0.00108	0.00234	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Bleomycin—germ cell cancer	0.00108	0.00234	CcSEcCtD
Cyclobenzaprine—Constipation—Ifosfamide—germ cell cancer	0.00107	0.00232	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Etoposide—germ cell cancer	0.00106	0.00231	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Cisplatin—germ cell cancer	0.00106	0.00229	CcSEcCtD
Cyclobenzaprine—Tachycardia—Cisplatin—germ cell cancer	0.00105	0.00229	CcSEcCtD
Cyclobenzaprine—Asthenia—Bleomycin—germ cell cancer	0.00105	0.00228	CcSEcCtD
Cyclobenzaprine—Convulsion—Etoposide—germ cell cancer	0.00105	0.00228	CcSEcCtD
Cyclobenzaprine—Hypertension—Etoposide—germ cell cancer	0.00104	0.00227	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00104	0.00226	CcSEcCtD
Cyclobenzaprine—Pruritus—Bleomycin—germ cell cancer	0.00104	0.00225	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00103	0.00224	CcSEcCtD
Cyclobenzaprine—Chest pain—Etoposide—germ cell cancer	0.00103	0.00224	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Methotrexate—germ cell cancer	0.00103	0.00224	CcSEcCtD
Cyclobenzaprine—Nausea—Vinblastine—germ cell cancer	0.00103	0.00224	CcSEcCtD
Cyclobenzaprine—Anorexia—Cisplatin—germ cell cancer	0.00103	0.00223	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00102	0.00222	CcSEcCtD
Cyclobenzaprine—Discomfort—Etoposide—germ cell cancer	0.00102	0.00221	CcSEcCtD
Cyclobenzaprine—Hypotension—Cisplatin—germ cell cancer	0.00101	0.00219	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00101	0.00218	CcSEcCtD
Cyclobenzaprine—Confusional state—Etoposide—germ cell cancer	0.000996	0.00216	CcSEcCtD
Cyclobenzaprine—Urticaria—Ifosfamide—germ cell cancer	0.000993	0.00216	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Ifosfamide—germ cell cancer	0.000989	0.00215	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Methotrexate—germ cell cancer	0.000988	0.00215	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Etoposide—germ cell cancer	0.000988	0.00215	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000982	0.00213	CcSEcCtD
Cyclobenzaprine—Asthenia—Dactinomycin—germ cell cancer	0.000979	0.00213	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Cisplatin—germ cell cancer	0.000968	0.0021	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Etoposide—germ cell cancer	0.000967	0.0021	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000967	0.0021	CcSEcCtD
Cyclobenzaprine—Tachycardia—Etoposide—germ cell cancer	0.000964	0.00209	CcSEcCtD
Cyclobenzaprine—HTR2A—brain—germ cell cancer	0.000961	0.00367	CbGeAlD
Cyclobenzaprine—Dyspnoea—Cisplatin—germ cell cancer	0.000961	0.00209	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Methotrexate—germ cell cancer	0.000958	0.00208	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Etoposide—germ cell cancer	0.000955	0.00207	CcSEcCtD
Cyclobenzaprine—Anorexia—Etoposide—germ cell cancer	0.000941	0.00205	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Cisplatin—germ cell cancer	0.000937	0.00204	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dactinomycin—germ cell cancer	0.000934	0.00203	CcSEcCtD
Cyclobenzaprine—Vomiting—Bleomycin—germ cell cancer	0.00093	0.00202	CcSEcCtD
Cyclobenzaprine—Drowsiness—Methotrexate—germ cell cancer	0.000928	0.00201	CcSEcCtD
Cyclobenzaprine—Hypotension—Etoposide—germ cell cancer	0.000923	0.002	CcSEcCtD
Cyclobenzaprine—Rash—Bleomycin—germ cell cancer	0.000923	0.002	CcSEcCtD
Cyclobenzaprine—Dermatitis—Bleomycin—germ cell cancer	0.000922	0.002	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000921	0.002	CcSEcCtD
Cyclobenzaprine—Stomatitis—Methotrexate—germ cell cancer	0.000904	0.00196	CcSEcCtD
Cyclobenzaprine—Asthenia—Ifosfamide—germ cell cancer	0.000897	0.00195	CcSEcCtD
Cyclobenzaprine—Sweating—Methotrexate—germ cell cancer	0.000889	0.00193	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Cisplatin—germ cell cancer	0.000888	0.00193	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Etoposide—germ cell cancer	0.000887	0.00193	CcSEcCtD
Cyclobenzaprine—Pruritus—Ifosfamide—germ cell cancer	0.000885	0.00192	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Etoposide—germ cell cancer	0.00088	0.00191	CcSEcCtD
Cyclobenzaprine—Somnolence—Etoposide—germ cell cancer	0.000878	0.00191	CcSEcCtD
Cyclobenzaprine—CYP2D6—brain—germ cell cancer	0.000876	0.00334	CbGeAlD
Cyclobenzaprine—Nausea—Bleomycin—germ cell cancer	0.000869	0.00189	CcSEcCtD
Cyclobenzaprine—Vomiting—Dactinomycin—germ cell cancer	0.000868	0.00188	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Methotrexate—germ cell cancer	0.000866	0.00188	CcSEcCtD
Cyclobenzaprine—Rash—Dactinomycin—germ cell cancer	0.00086	0.00187	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Etoposide—germ cell cancer	0.000859	0.00187	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Ifosfamide—germ cell cancer	0.000856	0.00186	CcSEcCtD
Cyclobenzaprine—Fatigue—Etoposide—germ cell cancer	0.000851	0.00185	CcSEcCtD
Cyclobenzaprine—Constipation—Etoposide—germ cell cancer	0.000845	0.00183	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—germ cell cancer	0.000833	0.00181	CcSEcCtD
Cyclobenzaprine—Dizziness—Ifosfamide—germ cell cancer	0.000827	0.0018	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—germ cell cancer	0.000826	0.0018	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Etoposide—germ cell cancer	0.000814	0.00177	CcSEcCtD
Cyclobenzaprine—Nausea—Dactinomycin—germ cell cancer	0.000811	0.00176	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000808	0.00175	CcSEcCtD
Cyclobenzaprine—Vomiting—Ifosfamide—germ cell cancer	0.000795	0.00173	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Cisplatin—germ cell cancer	0.000794	0.00173	CcSEcCtD
Cyclobenzaprine—Rash—Ifosfamide—germ cell cancer	0.000788	0.00171	CcSEcCtD
Cyclobenzaprine—Dermatitis—Ifosfamide—germ cell cancer	0.000788	0.00171	CcSEcCtD
Cyclobenzaprine—Urticaria—Etoposide—germ cell cancer	0.000785	0.0017	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Etoposide—germ cell cancer	0.000781	0.0017	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—germ cell cancer	0.000776	0.00169	CcSEcCtD
Cyclobenzaprine—Asthenia—Cisplatin—germ cell cancer	0.000773	0.00168	CcSEcCtD
Cyclobenzaprine—Nausea—Ifosfamide—germ cell cancer	0.000743	0.00161	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Cisplatin—germ cell cancer	0.000738	0.0016	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—germ cell cancer	0.000736	0.0016	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Etoposide—germ cell cancer	0.000728	0.00158	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Methotrexate—germ cell cancer	0.00071	0.00154	CcSEcCtD
Cyclobenzaprine—Asthenia—Etoposide—germ cell cancer	0.000709	0.00154	CcSEcCtD
Cyclobenzaprine—Pruritus—Etoposide—germ cell cancer	0.000699	0.00152	CcSEcCtD
Cyclobenzaprine—Vomiting—Cisplatin—germ cell cancer	0.000685	0.00149	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—germ cell cancer	0.000683	0.00148	CcSEcCtD
Cyclobenzaprine—Rash—Cisplatin—germ cell cancer	0.00068	0.00148	CcSEcCtD
Cyclobenzaprine—Dermatitis—Cisplatin—germ cell cancer	0.000679	0.00148	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Etoposide—germ cell cancer	0.000676	0.00147	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000673	0.00146	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—germ cell cancer	0.000654	0.00142	CcSEcCtD
Cyclobenzaprine—Dizziness—Etoposide—germ cell cancer	0.000653	0.00142	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—germ cell cancer	0.000651	0.00141	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—germ cell cancer	0.000649	0.00141	CcSEcCtD
Cyclobenzaprine—Nausea—Cisplatin—germ cell cancer	0.00064	0.00139	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—germ cell cancer	0.000628	0.00136	CcSEcCtD
Cyclobenzaprine—Vomiting—Etoposide—germ cell cancer	0.000628	0.00136	CcSEcCtD
Cyclobenzaprine—Rash—Etoposide—germ cell cancer	0.000623	0.00135	CcSEcCtD
Cyclobenzaprine—Dermatitis—Etoposide—germ cell cancer	0.000622	0.00135	CcSEcCtD
Cyclobenzaprine—Headache—Etoposide—germ cell cancer	0.000619	0.00134	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—germ cell cancer	0.000617	0.00134	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—germ cell cancer	0.000617	0.00134	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—germ cell cancer	0.00061	0.00132	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—germ cell cancer	0.000596	0.0013	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000592	0.00129	CcSEcCtD
Cyclobenzaprine—Nausea—Etoposide—germ cell cancer	0.000587	0.00127	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000579	0.00126	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000572	0.00124	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—germ cell cancer	0.000564	0.00122	CcSEcCtD
Cyclobenzaprine—Hypotension—Methotrexate—germ cell cancer	0.000553	0.0012	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000539	0.00117	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—germ cell cancer	0.000535	0.00116	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—germ cell cancer	0.000531	0.00115	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—germ cell cancer	0.000527	0.00115	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—germ cell cancer	0.000526	0.00114	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—germ cell cancer	0.000521	0.00113	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—germ cell cancer	0.000514	0.00112	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—germ cell cancer	0.00051	0.00111	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methotrexate—germ cell cancer	0.000487	0.00106	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000484	0.00105	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—germ cell cancer	0.00047	0.00102	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—germ cell cancer	0.000468	0.00102	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—germ cell cancer	0.000436	0.000947	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—germ cell cancer	0.000424	0.000922	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—germ cell cancer	0.000419	0.000909	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methotrexate—germ cell cancer	0.000405	0.000879	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—germ cell cancer	0.000391	0.00085	CcSEcCtD
Cyclobenzaprine—Vomiting—Methotrexate—germ cell cancer	0.000376	0.000817	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—germ cell cancer	0.000373	0.00081	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—germ cell cancer	0.000373	0.00081	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—germ cell cancer	0.000371	0.000805	CcSEcCtD
Cyclobenzaprine—Nausea—Methotrexate—germ cell cancer	0.000351	0.000763	CcSEcCtD
